Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
95.6 EUR | +1.06% | 0.00% | -7.18% |
01:05pm | Arkema: BlackRock holds less than 5% of the capital | CF |
Apr. 18 | Arkema to Acquire Majority Stake in Austria's Proionic | MT |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.32 for the current year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.18% | 7.58B | C+ | ||
+4.77% | 103B | A- | ||
-5.63% | 63.04B | A- | ||
+40.95% | 39.49B | B | ||
+10.00% | 36.62B | B | ||
+4.84% | 32.44B | A- | ||
+6.01% | 19.07B | B- | ||
+11.51% | 16.63B | C+ | ||
+18.30% | 15.14B | B- | ||
+5.60% | 14.73B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AKE Stock
- Ratings Arkema